Related Experiment Videos

A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator

K C Chou1, K D Watenpaugh, R L Heinrikson

  • 1Computer-Aided Drug Discovery, Pharmacia & Upjohn, Kalamazoo, Michigan 49007-4940, USA.

Insights

A 3D model of Tau protein kinase II (TPKII) reveals its structure and activation mechanism. This computational model, based on experimental data, aids in designing potential TPKII inhibitors.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Tau protein kinase II (TPKII) is a crucial enzyme composed of Cdk5 and Nck5a.
  • Its activation mechanism has been a long-standing puzzle, particularly regarding Cdk5 phosphorylation.
  • Nck5a's activation domain may adopt a cyclin-fold structure, similar to Cdk2-cyclin complexes.

Purpose of the Study:

  • To derive a 3D structural model of the Cdk5-Nck5a*-ATP complex.
  • To elucidate the structural basis of TPKII activation and identify key interacting residues.
  • To propose a mechanism for TPKII activation independent of Cdk5 phosphorylation.

Main Methods:

  • Computational modeling based on the X-ray structure of Cdk2-cyclinA-ATP.
  • Site-directed mutagenesis data integration.
  • Analysis of protein-protein interfaces and ATP binding pockets.

Main Results:

  • A 3D model of the Cdk5-Nck5a*-ATP complex compatible with experimental data was generated.
  • Key residues at the Cdk5-Nck5a* interface and ATP binding site were predicted.
  • The model highlights the interaction between Nck5a* and Cdk5's T-loop, crucial for catalytic activity.

Conclusions:

  • The study provides a structural framework for understanding TPKII function.
  • A mechanism explaining TPKII activation independent of Cdk5 phosphorylation is proposed.
  • The findings offer a basis for designing novel TPKII inhibitors.

Related Concept Videos